Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sanofi, Regeneron and FDA
Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD
Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary disease received approval from the Food and Drug Administration.
Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a chronic lung disease, commonly known as "smoker's lung", the companies said on Friday.
Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
Regeneron stock XX on XX after the company won FDA approval for Dupixent in chronic obstructive pulmonary disease, or COPD.
14h
Regeneron: Long-Term Defensive Investment
Regeneron's R&D expenses are projected to reach $5 billion, but the business remains highly profitable. Read why I rate REGN ...
2d
Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing ...
2d
Sanofi blockbuster drug wins clearance in US for lung disease
Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Helene death toll rises
'Days of Our Lives' star dies
Vance’s Pennsylvania rally
Hospitalized for burns
'SNL' launches 50th season
Rescue mission launched
NC dam failure ‘imminent’
Malibu coast earthquake
Chief adviser subpoenaed
Trump to visit Fayetteville
Earth's orbit new asteroid
ISR strikes Lebanon again
Szarewicz case update
NY ballot appeal rejected
Steward CEO to step down
KY sues Express Scripts
Faces fine to end Brazil ban
On Hezbollah leader's killing
Deposition in AI suit
Haney sues Garcia
Ukrainian drones shot down
Condemns Israeli strikes
Congestion fee bid denied
Dow closes at record high
121st loss of the season
Houthis attack US warships
Van Gogh paintings attacked
Congressional Gold Medal
Diocese reaches settlement
UNC digital IDs blocked
Human rabies death in MN
ICE: Convicts roaming free
Feedback